LCLiliana Faviola de la Cerda-Trujillo

Liliana Faviola de la Cerda-Trujillo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Liliana Faviola de la Cerda-Trujillo has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Alfredo Celis

    Division of Disciplines for the Development, Promotion and Preservation of Health, CUCS, U de G, Guadalajara, Jalisco, Mexico

    1 shared publication
  • Ana Miriam Saldaña-Cruz

    Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico

    1 shared publication
  • C. R. Lopez‐Lizárraga

    Division of Surgery Hospital Civil de Guadalajara "Dr. Juan I. Menchaca" Guadalajara Mexico

    1 shared publication
  • Carlos Gutiérrez-Chávez

    Department of General Surgery, Hospital Civil de Guadalajara "Dr. Juan I. Menchaca", Mexico

    1 shared publication
  • Carlos Rene López-Lizarraga

    Department of Surgery, Hospital Civil de Guadalajara "Dr. Juan I. Menchaca", Mexico

    1 shared publication
  • César Felipe Ploneda-Valencia

    Department of General Surgery, Hospital Civil de Guadalajara “Dr. Juan I. Menchaca”, Mexico

    1 shared publication

Latest Publications

  • Physical inactivity and excessive sucrose consumption are associated with higher serum lipids in subjects with Taq1B CETP polymorphism

    by W. Campos‐Perez, M. Perez‐Robles, N. Torres‐Castillo, S. C. Rodríguez‐Reyes, L. F. De la Cerda Trujillo, E. Navarro‐Muñiz, C. R. Lopez‐Lizárraga, I. M. Llamas‐Covarrubias, E. Martinez‐Lopez

    Background: Dyslipidaemias result from the interaction between genetic and environmental factors, including diet disequilibrium and physical inactivity. Among the genetic factors associated with serum lipids, the Taq1B CETP polymorphism has been investigated. The B1 allele has been considered as a risk factor for dyslipidaemia because of its association with greater CETP levels and higher serum triglycerides. The present study aimed to determine the role of the Taq1B polymorphism with lipid and anthropometric variables and its interaction with diet and physical activity.Methods: In total, 215 subjects were enrolled in this cross‐sectional study. Diet intake was evaluated using a 3‐day food consumption record and physical activity was determined in accordance with World Health Organization recommendations. The Taq1B CETP polymorphism was determined by allelic discrimination.Results: Subjects with the B1B2/B2B2 genotype, who had a sucrose consumption ≥5% of the total kcal day−1, had higher levels of total cholesterol (TC) [165.55 (142.21–188.89) mg dL−1 versus 200.19 (184.79–215.60) mg dL−1; P for interaction = 0.034] and low‐density lipoprotein [99.29 (75.52–123.05) mg dL−1 versus 128.64 (113.59–143.69) mg dL−1; P for interaction = 0.037] than subjects with the B1B1 genotype. Subjects who did not perform physical activity and had the B1B2/B2B2 genotype showed significantly higher levels of TC [177.48 (161.36–193.60) mg dL−1 versus 194.49 (185.43–203.56) mg mL−1; P for interaction = 0.033] than subjects with the B1B1 genotype.Conclusions: We provide evidence that subjects with inadequate environmental factors carriers of the polymorphic genotype had higher serum lipid levels than subjects with the B1B1 genotype.


  • Prognostic Factors for Permanent Work Disability in Patients With Rheumatoid Arthritis Who Received Combination Therapy of Conventional Synthetic Disease-Modifying Antirheumatic Drugs

    by M. Luisa Vazquez-Villegas, Jorge I. Gamez-Nava, Alfredo Celis, Dalia Sanchez-Mosco, Liliana F. de la Cerda-Trujillo, Jessica D. Murillo-Vazquez, A. Miriam Saldaña-Cruz, Miriam F. Alcaraz-Lopez, Valeria Diaz-Rizo, Jose Alvarez-Nemegyei, et al.

    Background: There is limited information about the factors related with the development of long-term permanent work disability (PWD) in rheumatoid arthritis (RA) treated with a combination of conventional synthetic disease-modifying antirheumatic drugs (cs-DMARDs). Objective: The aim of this study was to evaluate incidence and factors associated with the development of PWD in RA treated with combination therapy using conventional synthetic cs-DMARDs. Methods: We assessed in multivariate models the effect of clinical and demographic factors in the development of PWD in a long-term retrospective cohort of 180 workers with RA who were treated with a combination of cs-DMARDs. Results: Incidence rates of PWD were 2.2% at 1 year, 7.7% at 5 years, 24.9% at 10 years, 34.9% at 15 years, and 45% at 20 years. In the adjusted Cox regression analysis, factors associated with PWD development were the first failure with combination of cs-DMARDs (hazard ratio [HR], 2.4; 95% confidence interval [CI], 1.05–5.46; P = 0.03), poor functioning at time of cohort onset (HR, 2.2; 95% CI, 1.05–4.70; P = 0.03), and requirement for joint replacement (HR, 3.3; 95% CI, 1.28–8.79; P = 0.01). Conclusions: Around 25% of workers with combination therapy with cs-DMARDs developed PWD in 10 years following the diagnosis of RA. Some factors increase the risk of disability. Permanent work disability generates a relevant society burden and increases health care costs. Therefore, indicators predicting failure of combination therapies with cs-DMARDs might provide clinicians of useful tools for modifying treatments avoiding the disease progression.


  • Acute appendicitis in an overweight and obese Mexican population: A retrospective cohort study

    by Eduardo Sotelo-Anaya, Martha Patricia Sánchez-Muñoz, César Felipe Ploneda-Valencia, Liliana Faviola de la Cerda-Trujillo, Oscar Varela-Muñoz, Carlos Gutiérrez-Chávez, Carlos Rene López-Lizarraga